WebMD Oncology News

Reovirus is harmless to normal cells -- but it destroys many kinds of cancer cells. A new study in patients with prostate cancer takes the virus closer to being a new cancer treatment.

A new kind of cancer test can tell whether -- and when -- a tumor is coming back after initial treatment. The test IDs gene signatures unique to the tumor and may be ready in 2 or 3 years.

PERC, a chemical used in dry cleaning, is a "likely human carcinogen," the National Academy of Sciences says.

Cancer its treatment can be painful -- but many patients also suffer intense bouts of sudden, crippling pain. Nearly half say treatment does not control this breakthrough pain.

WebMD explains how to be sure you're getting the best cancer care, how to find out about clinical trials, and when you should travel for treatment.

When you're getting treatment for cancer, your body is under assault -- both from the cancer and the treatment itself. So it's more important than ever to get the nutrients, vitamins, and minerals you need to stay strong.

There is mounting evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) may help prevent or slow the growth of non-melanoma skin cancers.

Two newly discovered genes may act as master control switches in the progression of the most aggressive form of brain cancer, glioblastoma, a study shows.

The first genetic maps of lung cancer and melanoma reveal the pivotal role of smoking and sunlight in triggering these two deadly forms of cancer.

Radiation doses from CT scans are often high and vary widely, and excessively high doses may contribute substantially to future cancers, a study shows.

Substances in the milk thistle plant may help treat inflammation of the liver in cancer patients undergoing chemotherapy, a new study shows.

New cancer cases and the cancer death rate continue to fall in the U.S., driven largely by declines in lung, prostate, and colorectal cancers in men and breast and colorectal cancers in women.